Legal Opinion
Amgen, Inc. v. United States International Trade Commission, Chugai Pharmaceutical Co., Ltd. And Chugai Pharma U.S.A., Inc., Intervenors
Court of Appeals for the Federal Circuit
Decided April 27, 1990No. 19-2072PublishedCited by 35 opinions
1Opinion of the Court
RICH, Circuit Judge.
Amgen, Inc. (Amgen) appeals from the April 10, 1989 Order of the United States International Trade Commission (Commission), Inv. No. 337-TA-281 entitled Certain Recombinant Erythropoietin, 10 USPQ2d 1906 (USITC 1989), dismissing its complaint for lack of subject matter jurisdiction. We vacate and remand.
BACKGROUND
Erythropoietin is a hormone which controls the synthesis of red blood cells in bone marrow and which is useful for treating patients suffering from anemia. Because the amount of erythropoietin naturally present in humans and animals is very small, it is…
2Cases cited13 opinions
- Scheuer v. RhodesSupreme Court of the United States · 1974
- Bell v. HoodSupreme Court of the United States · 1946
- Diamond v. ChakrabartySupreme Court of the United States · 1980
- Underwriters National Assurance Co. v. North Carolina Life & Accident & Health Insurance Guaranty Ass'nSupreme Court of the United States · 1982
- Federal Trade Commission v. Raladam Co.Supreme Court of the United States · 1931
8 more not listed; retrieve them via the Exa API.
3Cited by35 opinions
- Amgen, Inc., Plaintiff/cross-Appellant v. Chugai Pharmaceutical Co., Ltd., and Genetics Institute, Inc.Court of Appeals for the Federal Circuit · 1991
- Roland Spruill v. Merit Systems Protection BoardCourt of Appeals for the Federal Circuit · 1992
- James L. Lewis v. United StatesCourt of Appeals for the Federal Circuit · 1995
- Kinik Company v. International Trade Commission, and Minnesota Mining and Manufacturing Company and Ultimate Abrasive Systems, L.L.C., IntervenorsCourt of Appeals for the Federal Circuit · 2004
- Vanalco, Inc. v. United StatesUnited States Court of Federal Claims · 2000
30 more not listed; retrieve them via the Exa API.